Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
The Rx Consultant 

Probiotic Use in Children


This CE activity was originally published in The Rx Consultant.  If you received credit for it previously, you cannot receive credit for it again.
 
A flood of probiotic products has hit the market, and consumer interest in the potential health benefits of “good bacteria” is growing rapidly. Over the 12-month period from 2010 to 2011, sales of probiotic-containing foods grew by over 30% in the U.S., with consumer spending on foods and supplements reaching nearly $1.2 billion. As early as 2007, “prebiotics or probiotics” were ranked the fifth most frequently used nonvitamin, nonmineral, natural product in children. The number of human studies of probiotics has quadrupled since 2000, with a wide range of potential therapeutic and preventive uses – including gastrointestinal (GI) disorders, allergy, and infections – being evaluated.

Probiotics are available in the U.S. as dietary supplements (including capsules, tablets, powders) and in infant formulas and dairy foods such as yogurt. Selected products are detailed on page 4. Despite increased awareness of probiotics, many consumers are confused about what they contain, what effects they have on the body, which strains or products are the best choices, and how to use them. Consumers may not be aware that, despite the growth in research, there is not yet strong scientific evidence to support many of the health claims for probiotics. This issue gives a general overview of probiotics, including common strains, safety, dosing, and current regulatory issues. Commonly studied conditions for probiotic use in children, namely acute infectious diarrhea, antibiotic-associated diarrhea, and eczema (atopic dermatitis), will be discussed in detail. The community healthcare provider is uniquely positioned to help consumers sort out the facts and misconceptions about probiotics, so they can make informed choices.
Format
This CE activity is a monograph (PDF file).

Fee

$10.00

CE Hours

1.50

CE Units

0.150

Activity Type

  • Knowledge-based

Target Audience(s)

  • Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, and Registered Nurses

Accreditation(s)

This CE activity was developed by The Rx Consultant, a publication of Continuing Education Network, Inc.

CE activities for Pharmacists and Pharmacy Technicians:
This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours.  CE credit is automatically reported to CPE Monitor.
 
CE activities for Nurse Practitioners and Clinical Nurse Specialists: 
    This continuing education activity meets the requirements of:
        The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics.
        The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE.
 
    This is a pharmacotherapeutics/pharmacology CE activity.
  • The ANCC requires all advanced practice nursing certificants (CNSs and NPs) to complete 25 CE hours of pharmacotherapeutics as a portion of the required 75 continuing education hours.
  • Pharmacology CE is recommended by the AANPCP and will be required for Certificants renewing certification starting January 2017.  
  • Most State Boards of Nursing require a minimum number of pharmacy contact hours to renew an advanced practice license.
 
 
Accreditation Council for Pharmacy Education
Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

CE No Longer Valid
 
To receive CE credit, the participant must read the monograph in its entirety, complete the online post-test and receive a score of 70% or greater, and complete the online evaluation.
 
Pharmacists and Pharmacy Technicians -
 
Be sure your profile has been updated with your NAPB e-profile # and birth date information BEFORE completing the online evaluation, or your credits cannot be reported to CPE Monitor.
 
Continuing pharmacy education credit is automatically reported to CPE Monitor once the post-test & evaluation are successfully completed.

 

 

 

Objectives

  • Define probiotic, and describe how probiotics differ from prebiotics, synbiotics, and live active cultures. Describe at least 2 mechanisms by which probiotics may act.
  • Name at least 3 widely used probiotic species. Discuss the importance of the specific strain to probiotic effects.
  • Discuss the evidence for probiotic use in the prevention and treatment of acute infectious diarrhea, antibiotic-associated diarrhea, C. difficile infection, and eczema in children.

Speaker(s)/Author(s)

Bob John, PharmD, BCPS


Brief Bio : Bob John, PharmD, BCPS, Assistant Professor, Pharmacy Dept., College of Pharmacy and Pediatric Dept., College of Medicine, University of Oklahoma.
Disclosure : Dr. John report no financial or personal relationship with any commercial interest producing, marketing, reselling, or distributing a product or service that appears in this issue.

Brooke L. Honey, PharmD, BCPS, AE-C


Brief Bio : Brooke L. Honey, PharmD, BCPS, AE-C, Assistant Professor, Pharmacy Dept., College of Pharmacy and Pediatric Dept., College of Medicine, University of Oklahoma
Disclosure : Dr. Honey report no financial or personal relationship with any commercial interest producing, marketing, reselling, or distributing a product or service that appears in this issue.

Pamela Mausner, MD


Brief Bio : Pamela Mausner, MD; Medical Writer/Editor and Healthcare Advocate; and Associate Editor, The Rx Consultant.
Disclosure : Dr.Mausner reports no financial relationship with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) that appear in this issue.

Tracy Farnen, PharmD


Brief Bio : Tracy Farnen, PharmD; Managing Editor, The Rx Consultant.
Disclosure : Dr. Farnen reports no financial relationship with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) that appear in this issue.

Activity Number

0428-0000-13-001-H01-P

Release Date: Dec 18, 2012
Credit Expiration Date: Dec 18, 2015

CE Hours

1.50

Fee

$10.00